Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer
1 Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
3 Shanghai Genitourinary Cancer Institute, Shanghai, China.
4 Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
5 Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
6 Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
7 Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
8 Department of Surgery, and SH Ho Urology Center, Chinese University of Hong Kong, Hong Kong, Hong Kong.
9 Department of Urology, Nagoya University Graduate School of Medicine, Aichi, Japan.
10 Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
11 Oncology Academic Programme, Duke-NUS Medical School, Singapore.